NYSE:PBH - Prestige Brands Stock Price, News, Headlines & Rumors

Prestige Brands trades on the New York Stock Exchange (NYSE) under the ticker symbol "PBH."

Prestige Brands Holdings, Inc. (NYSE:PBH) posted its quarterly earnings data on Thursday, August, 2nd. The company reported $0.68 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $0.67 by $0.01. The firm earned $253.98 million during the quarter, compared to analyst estimates of $253.70 million. Prestige Brands had a net margin of 32.76% and a return on equity of 12.45%. The company's revenue for the quarter was down 1.0% on a year-over-year basis. During the same quarter last year, the business posted $0.66 EPS. View Prestige Brands' Earnings History.

Prestige Brands is scheduled to release their next quarterly earnings announcement on Thursday, November, 1st 2018. View Earnings Estimates for Prestige Brands.

Prestige Brands issued an update on its FY19 earnings guidance on Thursday, August, 2nd. The company provided earnings per share (EPS) guidance of $2.84-2.92 for the period, compared to the Thomson Reuters consensus estimate of $2.91. The company issued revenue guidance of $985-995 million, compared to the consensus revenue estimate of $1.00 billion.

6 Wall Street analysts have issued 1-year price targets for Prestige Brands' shares. Their forecasts range from $33.00 to $125.00. On average, they anticipate Prestige Brands' stock price to reach $71.40 in the next year. This suggests a possible upside of 91.7% from the stock's current price. View Analyst Price Targets for Prestige Brands.

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Prestige Brands in the last year. There are currently 2 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Prestige Brands.

Some companies that are related to Prestige Brands include Bausch Health Companies (BHC), SAGE Therapeutics (SAGE), Alkermes (ALKS), Ionis Pharmaceuticals (IONS), GALAPAGOS NV/S (GLPG), United Therapeutics (UTHR), Catalent (CTLT), Dr.Reddy's Laboratories (RDY), Ligand Pharmaceuticals (LGND), FibroGen (FGEN), Loxo Oncology (LOXO), Agios Pharmaceuticals (AGIO), HUTCHISON CHINA/S (HCM), Taro Pharmaceutical Industries (TARO) and Ultragenyx Pharmaceutical (RARE).

News articles about PBH stock have trended positive this week, Accern Sentiment Analysis reports. The research firm rates the sentiment of press coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Prestige Brands earned a media and rumor sentiment score of 0.37 on Accern's scale. They also gave news headlines about the company an impact score of 45.50 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company's share price in the immediate future. View Recent Headlines for Prestige Brands.

Prestige Brands' stock is owned by a variety of of institutional and retail investors. Top institutional investors include BlackRock Inc. (12.28%), FMR LLC (11.37%), Dimensional Fund Advisors LP (6.19%), Wells Fargo & Company MN (4.24%), Fuller & Thaler Asset Management Inc. (3.84%) and Fisher Asset Management LLC (2.62%). Company insiders that own Prestige Brands stock include Gary E Costley, Jean A Boyko, Natale S Ricciardi, Ronald M Lombardi and William P'pool. View Institutional Ownership Trends for Prestige Brands.

PBH stock was sold by a variety of institutional investors in the last quarter, including OppenheimerFunds Inc., Cortina Asset Management LLC, Russell Investments Group Ltd., Standard Life Aberdeen plc, Aristotle Capital Boston LLC, Millennium Management LLC, Olstein Capital Management L.P. and California Public Employees Retirement System. View Insider Buying and Selling for Prestige Brands.

PBH stock was acquired by a variety of institutional investors in the last quarter, including Dimensional Fund Advisors LP, FMR LLC, Fuller & Thaler Asset Management Inc., BlackRock Inc., Wells Fargo & Company MN, LSV Asset Management, Aristotle Fund L.P. and Bank of America Corp DE. Company insiders that have bought Prestige Brands stock in the last two years include Gary E Costley, Natale S Ricciardi, Ronald M Lombardi and William P'pool. View Insider Buying and Selling for Prestige Brands.

Shares of PBH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of PBH stock can currently be purchased for approximately $37.24.

Prestige Brands has a market capitalization of $1.94 billion and generates $1.04 billion in revenue each year. The company earns $339.57 million in net income (profit) each year or $2.58 on an earnings per share basis. Prestige Brands employs 530 workers across the globe.

Prestige Brands' mailing address is 660 WHITE PLAINS ROAD, TARRYTOWN NY, 10591. The company can be reached via phone at 914-524-6800 or via email at [email protected]